Fluorescence-Guided Breast Cancer Surgery: International Pivotal Phase III RCT receives FDA IND Clearance
https://dacostalab.ca/wp-content/uploads/2021/04/US-food-and-drug-display-pic-1030x579.png 1030 579 DaCosta Lab DaCosta Lab https://dacostalab.ca/wp-content/uploads/2021/04/US-food-and-drug-display-pic-1030x579.pngToday, SBI ALApharma Canada Inc., a subsidiary of photonamic GmbH & Co. KG ( Pinneberg, Germany), a subsidiary of SBI Holdings, Inc. (Minato-ku, Tokyo); received FDA Investigational New Drug (IND) clearance for its Pivotal Phase III randomized controlled trial (RCT) evaluating the safety and efficacy of PD G 506 A (5-ALA HCl) in intraoperative margin assessment during…
read more